Actively Recruiting
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
Led by Columbia University · Updated on 2025-10-21
12
Participants Needed
2
Research Sites
578 weeks
Total Duration
On this page
Sponsors
C
Columbia University
Lead Sponsor
N
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Rapid onset Obesity, Hypoventilation, Hypothalamic dysfunction and Autonomic Dysregulation (ROHHAD) is a syndrome named in 2007. The hallmark of the syndrome is the rapid onset obesity and dysregulation of central ventilation. There is little information about the metabolic changes that lead to the rapid onset obesity in these children. The investigators would like to study the metabolic phenotype of these children to understand the disturbances in energy balance that lead to the rapid onset obesity.
CONDITIONS
Official Title
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children with ROHHAD syndrome
You will not qualify if you...
- Children with known genetic causes of obesity
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Boston Children's Hospital
Boston, New York, United States, 02115
Completed
2
Columbia University Irving Medical Center
New York, New York, United States, 10032
Actively Recruiting
Research Team
V
Vidhu Thaker, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here